The 12 closest competitors and alternatives to Gritstone bio, Inc. among healthcare companies — ranked by similarity to what Gritstone bio, Inc. actually does, not by market-cap band.
Subscribe to see Gritstone bio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Gritstone bio, Inc. is a clinical-stage biotechnology company headquartered in Emeryville, California. The firm engages in developing next-generation cancer immunotherapies and vaccines to fight various forms of cancer and infectious diseases.
Gritstone bio, Inc. is a healthcare company headquartered in United States. It has raised at least $295M across the 4 funding rounds on record. Its most recent funding round raised $45M in October 2022. Xcout tracks 2 named people at Gritstone bio, Inc., including Wayne Robinson (CEO).
At least $295M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $45M | — | |
| SEC Form D filing | $55M | — | |
| Series B | $93M | — | |
| Series A | $102M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Gritstone bio, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Sift Biosciences is a privately held biotechnology company founded in 2024 and headquartered in San Carlos, California. The company is focused on harnessing pre-existing hidden immunity.
Biotech
Enara Bio, Ltd. is a UK biotechnology company that discovers cancer targets, including tumor-specific antigens, using immunopeptidomics and machine-learning technologies. It works with biopharmaceutical companies to support development of cancer vaccines and other targeted immunotherapies.
Biotechnology
Tessellate Bio is a biotechnology company that develops precision oncology medicines by exploring synthetic lethal interactions beyond homologous recombination deficiency. The company integrates biomarker discovery and companion diagnostics into its research programs to create first-in-class treatments for hard-to-treat cancers.
Similar healthcare company
GENEOS Therapeutics, Inc. is a biotechnology company focused on developing exquisitely personalized, EPIC-based cancer immunotherapies. The company is headquartered in Philadelphia, Pennsylvania, United States.
Similar healthcare company
GEn1E Lifesciences Inc. is a clinical-stage, Phase 2 biotechnology research company based in Palo Alto, California, focused on accelerating novel precision therapies.
Health Care
ExpreS2ion Biotech Holding is a clinical-stage biotechnology company that develops innovative immunotherapies and vaccines to treat cancer and prevent infectious diseases. Utilizing its proprietary ExpreS2 protein expression system and a virus-like particle delivery platform, the company creates candidates such as its lead HER2 cancer immunotherapy, ES2B-C001.
Similar healthcare company
Infinitopes is a biotechnology research company based in Oxford, United Kingdom, focused on developing revolutionary off-the-shelf precision vaccines to prevent deaths from cancer metastases.
Biotechnology
Excision BioTherapeutics Inc. is a San Francisco-based clinical-stage biotechnology company focused on developing advanced gene editing therapeutics to treat infectious diseases.
Biotechnology
Affini-T Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, specializing in the development of precision immunotherapies and T-cell therapies for cancer patients.
Therapeutics
CorriXR Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Delaware, United States. The firm focuses on developing innovative drug pipelines and oncology therapeutics to address unmet medical needs.
Biotechnology
Flashpoint Therapeutics is a clinical-stage biotechnology research company headquartered in Evanston, Illinois, developing a new class of precision-engineered structural nanomedicines through its proprietary platform.
Biotechnology
Silverback Therapeutics, Inc. is a biopharmaceutical company focused on leveraging its proprietary ImmunoTAC technology platform to develop therapeutic products.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Gritstone bio, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →